-+ 0.00%
-+ 0.00%
-+ 0.00%

William Blair Initiates Coverage On Aardvark Therapeutics with Outperform Rating

Benzinga·12/12/2025 16:27:50
Listen to the news
William Blair analyst Andy Hsieh initiates coverage on Aardvark Therapeutics (NASDAQ:AARD) with a Outperform rating.